Table 2 Propensity score-adjusted logistic regression analysis of choice of treatment with best supportive care alone.
Variable | Univariate Analysis | Multivariate Analysis | ||||
|---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | |
Age (low → high) | 1.08 | 1.05–1.11 | 0.0001 | 1.11 | 1.05–1.16 | 0.0001 |
Dementia (absent vs. present) | 20.4 | 5.85–71.4 | 0.0001 | 37.0 | 6.54 –200.0 | 0.0001 |
Performance status (0 → 4) | 3.77 | 2.83–5.03 | 0.0001 | 6.10 | 3.83–9.71 | 0.0001 |
Patient’s desire for best supportive care alone (absent vs. present) | 4.02 | 2.22–7.30 | 0.0001 | 22.2 | 6.71–76.9 | 0.0001 |
Pulmonary disease (absent vs. present) | 2.13 | 1.34–3.39 | 0.001 | 3.83 | 1.64–8.93 | 0.002 |
Epidermal growth factor receptor mutation (mutant vs. wild type) | 2.97 | 2.00–4.42 | 0.0001 | 2.68 | 1.29–5.56 | 0.008 |
Social background (absent vs. present) | 3.39 | 1.46–7.81 | 0.004 | 5.44 | 1.22–24.4 | 0.027 |
Psychiatric disorder (absent vs. present) | 4.65 | 1.49–14.5 | 0.008 | 9.09 | 1.26–66.7 | 0.029 |
Renal dysfunction (absent vs. present) | 2.52 | 1.25–5.08 | 0.010 | 3.18 | 0.92–11.0 | 0.068 |
Blood disease (absent vs. present) | 6.67 | 1.27–34.5 | 0.025 | 6.37 | 0.69–58.8 | 0.103 |
Aspartic acid aminotransferase (low → high) | 1.02 | 1.002–1.03 | 0.031 | 1.01 | 0.99–1.03 | 0.366 |
Sex (female → male) | 1.57 | 0.94–2.64 | 0.086 | 1.36 | 0.51–3.64 | 0.534 |
Histologic type (adenocarcinoma vs. others) | 2.94 | 1.81–4.79 | 0.0001 |  | NI |  |
Albumin (low → high) | 0.53 | 0.38–0.75 | 0.0001 |  | NI |  |
Lactate dehydrogenase (×103) (low → high) | 83.3 | 12.4–500.0 | 0.0001 |  | NI |  |
Doctor’s recommendation about best supportive care (absent vs. present) | 32.3 | 10.3–100.0 | 0.0001 |  | NI |  |
C-reactive protein (low → high) | 1.16 | 1.10–1.23 | 0.0001 |  | NI |  |
White blood cells (×103) (low → high) | 1.11 | 1.05–1.17 | 0.0001 |  | NI |  |
Stage (1 → 4) | 1.27 | 1.10–1.46 | 0.001 |  | NI |  |